That said, Germany remains deeply engaged with GLP-1 research, accounting for 12.4% of all global GLP-1 clinical trial activity in 2025, according to GlobalDatas trials database
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults With Obesity
Last reviewed: April 2026
doi: 10.1186/s12933-025-02607-w 32 BaggioLLYustaBMulvihillEECaoXStreutkerCJButanyJet al
But I think one is that, you know, I learned from my long Covid experience, even how internally ableist I was, and I think ableism and weight ism or whatever, you know, like people not looking optimally healthy, whatever that means, actually sometimes pushes people to do things that are less actually healthy but look healthier, you know
In seven large cardiovascular studies, all agents shown at least non-inferiority, with liraglutide, subcutaneous semaglutide, and dulaglutide revealing statistically significant decreases in cardiovascular outcomes (Sheahan et al